Skip to content

To study Efficacy of Bringrajadi Churna in Iron Deficiency Anemia

A Randomized Controlled Clinical Study to evaluate the efficacy of Bhringrajadi Churna in the Management of Pandu (Iron Deficiency Anemia) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101911
Enrollment
40
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Dr Ashish Chougule
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects in between 21 to 60 years irrespective of gender having sign and symptoms of Pandu Roga (Iron deficiency anemia) 2 Haemoglobin level:less than 12gm per dl in non pregnant women and less than 13gm per dl in men. 3 MCV level less than 80fL and MCH less than 27pg 4 Willingness to participate and provide informed written consent.

Exclusion criteria

Exclusion criteria: 1 Severe Anemia (Hb less than 7 gm per dL). 2 Known case of haemolytic anemia Aplastic Anemia Thalassemia sickle cell Anemia or other genetic blood disorders. 3 Pandu(Iron Deficiency Anemia) associated with any chronic or systemic disorders. 4 History of recent blood transfusion (Within last 3 months) 5 Pregnant and lactating women. 6 Subjects on supplements of haematinics in any form in the last 30 days. 7 Any other illness which interferes with the intervention of the study.

Design outcomes

Primary

MeasureTime frame
Effect of Trial Drug on Improvement in the symptoms of Pandu (Iron deficiency Anemia)Timepoint: 15day,30day,45day.

Secondary

MeasureTime frame
Saftey of trial drug and Adverse Drug Reaction Aggravation of symptoms of Pandu (Iron deficiency Anemia)Timepoint: 15day,30day,45day.

Countries

India

Contacts

Public ContactDr Ashish Chougule

SDMTs AMC Post Graduation Centre Terdal

drmsb123@rediffmail.com9036701207

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026